Goldman Sachs analyst Julien Blouin initiated coverage of Omega Healthcare (OHI) with a Buy rating and $54 price target Channel checks and modeling point to meaningful upside in senior housing occupancy, RevPOR, and margins, though gains are likely capped longer term by vacancy, affordability, and supply, while also improving cash flow visibility for NNN structures and senior housing REIT investment opportunities, the analyst tells investors in a research note. Goldman expects the company to continue its shift towards Senior Housing NNN over time via acquisitions.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OHI:
- Omega Healthcare downgraded to Market Perform from Outperform at BMO Capital
- Omega Healthcare price target raised to $51 from $50 at UBS
- Omega Healthcare Amends Executive Contracts, Enhances Severance Terms
- Omega Healthcare price target raised to $45 from $43 at Jefferies
- Omega Healthcare price target raised to $46 from $44 at Truist